| [1] | Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(2023 report)[EB/OL]. http://goldcopd.org/2023-gold-report-2/. |
| [2] | BAFADHEL M, MCKENNA S, TERRY S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers[J]. Am J Respir Crit Care Med, 2011, 184(6): 662-671. doi: 10.1164/rccm.201104-0597OC |
| [3] | 慢性阻塞性肺疾病急性加重诊治专家组. 慢性阻塞性肺疾病急性加重诊治中国专家共识(2023年修订版)[J]. 国际呼吸杂志, 2023, 43(2): 132-149. doi: 10.3760/cma.j.cn131368-20221123-01066 |
| [4] | AARON S D. Management and prevention of exacerbations of COPD[J]. BMJ, 2014, 349: g5237. doi: 10.3109/9781420070873-35 |
| [5] | 景王慧, 吴文进, 燕茹, 等. 归肺经中药桑白皮的化学、药理与药代动力学研究进展[J]. 世界中医药, 2014, 9(1): 109-112,116. doi: 10.3969/j.issn.1673-7202.2014.01.039 |
| [6] | 李德顺, 李亚清. 定喘汤及其拆方治疗哮喘药理作用实验研究[J]. 天津中医学院学报, 2003(1): 16-18. doi: 10.3969/j.issn.1673-9043.2003.01.008 |
| [7] | ZHANG J H, WU X H, ZHONG B Y, et al. Review on the diverse biological effects of glabridin[J]. Drug Des Devel Ther, 2023, 17: 15-37. |
| [8] | 张迪, 夏艺, 范丽, 刘士远, 管宇. 慢性阻塞性肺疾病大鼠模型的建立与评价[J]. 中国实验动物学报, 2020, 28(02): 230-235. doi: 10.3969/j.issn.1005-4847.2020.02.012 |
| [9] | GALLI S J, BORREGAARD N, WYNN T A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils[J]. Nat Immunol, 2011, 12(11): 1035-1044. doi: 10.1038/ni.2109 |
| [10] | ZHAO H, MA Y T, ZHANG L F. Low-molecular-mass hyaluronan induces pulmonary inflammation by up-regulation of Mcl-1 to inhibit neutrophil apoptosis via PI3K/Akt1 pathway[J]. Immunology, 2018, 155(3): 387-395. |
| [11] | 陈玉文, 李诗琪, 黄小鹏, 等. 基于IL-6/STAT3、PI3K/Akt通路探讨汉黄芩素对LPS诱导的THP1巨噬细胞炎症模型的影响[J]. 中药材, 2022, 45(07): 1721-1725. doi: 10.13863/j.issn1001-4454.2022.07.035 |
| [12] | 昝慧, 王昌高, 张东艳, 等. IL-8通过激活PI3K/AKT通路促进结肠癌细胞增殖、迁移和侵袭[J]. 现代免疫学, 2020, 40(02): 137-141. |
| [13] | 叶欣园, 沈燚, 鲍荣华, 等. 金天格含药血清调控PI3K/Akt通路抑制TNF-α刺激的成纤维样滑膜细胞功能的机制[J/OL]. 中国中药杂志, 1-10. 2025-06-11. |
| [14] | ZHANG Q, QIAN D, TANG D D, et al. Glabridin from Glycyrrhiza glabra possesses a therapeutic role against keloid via attenuating PI3K/Akt and transforming growth factor-β1/SMAD signaling pathways[J]. J Agric Food Chem, 2022, 70(35): 10782-10793. doi: 10.1021/acs.jafc.2c02045 |
| [15] | SU L L, LI X D, WU X, et al. Simultaneous deactivation of FAK and Src improves the pathology of hypertrophic scar[J]. Sci Rep, 2016, 6: 26023. doi: 10.1038/srep26023 |
| [16] | ROSKOSKI R Jr. Src protein-tyrosine kinase structure and regulation[J]. Biochem Biophys Res Commun, 2004, 324(4): 1155-1164. |
| [17] | TORRY D S, COOPER G M. Proto-oncogenes in development and cancer[J]. Am J Reprod Immunol, 1991, 25(3): 129-132. |
| [18] | WANG C, GAO H, DONG J, et al. Insight into the medicinal chemistry of EGFR and HER-2 inhibitors[J]. Curr Med Chem, 2014, 21(11): 1336-1350. doi: 10.2174/0929867320666131119124646 |
| [19] | OHMORI T, YAMAOKA T, ANDO K, et al. Molecular and clinical features of EGFR-TKI-associated lung injury[J]. Int J Mol Sci, 2021, 22(2): 792. doi: 10.3390/ijms22020792 |
| [20] | YI G, LIANG M, LI M, et al. A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells[J]. Inflamm Res, 2018, 67(6): 539-551. doi: 10.1007/s00011-018-1145-8 |